GWS
MDT icon

Greykasell Wealth Strategies’s Medtronic MDT Stock Holding History

Greykasell Wealth Strategies’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14.1K Buy
163
+81
+99% +$7.76K 0.01% 364
2025
Q4 		$7.84K Buy
82
+1
+1% +$97 ﹤0.01% 382
2025
Q3 		$7.71K Buy
+81
New +$7.45K ﹤0.01% 315

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Greykasell Wealth Strategies's MDT Position: Q1 2026 in Review

Greykasell Wealth Strategies increased its Medtronic (MDT) stake by 99% in Q1 2026, buying an estimated $7.76K and bringing the position to 163 shares worth $14.1K. The position accounts for 0.01% of the portfolio, ranked #364.

Greykasell Wealth Strategies first reported a position in MDT in Q3 2025 and has held it in 3 quarters since. 2,238 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Greykasell Wealth Strategies held 163 shares of Medtronic worth $14.1K as of Q1 2026.
  • Greykasell Wealth Strategies bought 81 Medtronic shares in Q1 2026, an estimated $7.76K.
  • Medtronic made up 0.01% of Greykasell Wealth Strategies's portfolio in Q1 2026, its #364 holding.
  • Greykasell Wealth Strategies first reported a position in Medtronic in Q3 2025 and has held it in 3 quarters since.
  • 2,238 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Greykasell Wealth Strategies's 13F filing for Q1 2026, filed 7 May 2026.